Therapeutic Area | MeSH |
---|---|
neoplasms | D009369 |
hemic and lymphatic diseases | D006425 |
immune system diseases | D007154 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-hodgkin lymphoma | D008228 | — | C85.9 | 2 | 1 | 3 | — | — | 6 |
Lymphoma | D008223 | — | C85.9 | 2 | 1 | 1 | — | — | 4 |
Follicular lymphoma | D008224 | — | C82 | 1 | — | 2 | — | — | 3 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | — | — | 1 | — | — | 1 |
Leukemia | D007938 | — | C95 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 1 |
Drug common name | Pixantrone |
INN | pixantrone |
Description | Pixantrone is a member of isoquinolines. |
Classification | Small molecule |
Drug class | antineoplastics, anthraquinone derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NCCNc1ccc(NCCN)c2c1C(=O)c1ccncc1C2=O |
PDB | — |
CAS-ID | 144675-97-8 |
RxCUI | — |
ChEMBL ID | CHEMBL167731 |
ChEBI ID | — |
PubChem CID | 134019 |
DrugBank | DB06193 |
UNII ID | F5SXN2KNMR (ChemIDplus, GSRS) |